Mylène Pezet

Dr. Mylène Pezet

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YRYves Rival
Yves Rival
NBNathalie Benéteau
Nathalie Benéteau
TTThierry Taillandier
Thierry Taillandier
MPMylène Pezet
Mylène Pezet
EDElisabeth Dupont-Passelaigue
Elisabeth Dupont-Passelaigue
ADAndré Delhon
André Delhon

1 February 2008 in Rejuvenation Research
Verified
Journal Article
Closed access
MPMylène Pezet
Mylène Pezet
MJMarie-Paule Jacob
Marie-Paule Jacob
BEBrigitte Escoubet
Brigitte Escoubet
DGDealba Gheduzzi
Dealba Gheduzzi
ETEmmanuelle Tillet
Emmanuelle Tillet
GFGilles Faury
Gilles Faury
Elastin, the main component of elastic fibers, is synthesized only in early life and provides the blood vessels with their elastic properties. With aging, elastin is progressively degraded, leading to arterial enlargement, stiffening, and dysfunction. Also, elastin is a key regulator of vascular smooth muscle cell proliferation and migration during development since heterozygous mutations in its gene ( Eln ) are responsible for a severe obstructive vascular disease, supravalvular aortic stenosis, isolated or associated to Williams syndrome. Here, we have studied whether early elastin synthesis could also influence the aging processes, by comparing the structure and function of ascending aorta from 6- and 24-month-old Eln+/− and Eln+/+ mice. Eln+/− animals have high blood pressure and arteries with smaller diameters and more rigid walls containing additional although thinner elastic lamellas. Nevertheless, longevity of these animals is unaffected. In young adult Eln+/− mice, some features resemble vascular aging of wild-type animals: cardiac hypertrophy, loss of elasticity of the arterial wall through enhanced fragmentation of the elastic fibers, and extracellular matrix accumulation in the aortic wall, in particular in the intima. In Eln+/− animals, we also observed an age-dependent alteration of endothelial vasorelaxant function. On the contrary, Eln+/− mice were protected from several classical consequences of aging visible in aged Eln+/+ mice, such as arterial wall thickening and alteration of α 1 -adrenoceptor-mediated vasoconstriction. Our results suggest that early elastin expression and organization modify arterial aging through their impact on both vascular cell physiology and structure and mechanics of blood vessels.

9 December 2010 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
BMBoubacar Mariko
Boubacar Mariko
MPMylène Pezet
Mylène Pezet
BEBrigitte Escoubet
Brigitte Escoubet
SBStéphanie Bouillot
Stéphanie Bouillot
JAJean‐Pierre Andrieu
Jean‐Pierre Andrieu
GFGilles Faury
Gilles Faury

8 April 2008 in Circulation
Verified
Journal Article
Closed access
PDF file
BGBarnabas Gellen
Barnabas Gellen
MFMaría FernánDez-Velasco
María FernánDez-Velasco
FBFrançoIs Briec
FrançoIs Briec
LVLaurent Vinet
Laurent Vinet
KLKhai LeQuang
Khai LeQuang
JMJean-Jacques Mercadier
Jean-Jacques Mercadier
Background— Ca 2+ release from the sarcoplasmic reticulum via the ryanodine receptor (RyR2) activates cardiac myocyte contraction. An important regulator of RyR2 function is FKBP12.6, which stabilizes RyR2 in the closed state during diastole. β-Adrenergic stimulation has been suggested to dissociate FKBP12.6 from RyR2, leading to diastolic sarcoplasmic reticulum Ca 2+ leakage and ventricular tachycardia (VT). We tested the hypothesis that FKBP12.6 overexpression in cardiac myocytes can reduce susceptibility to VT in stress conditions. Methods and Results— We developed a mouse model with conditional cardiac-specific overexpression of FKBP12.6. Transgenic mouse hearts showed a marked increase in FKBP12.6 binding to RyR2 compared with controls both at baseline and on isoproterenol stimulation (0.2 mg/kg IP). After pretreatment with isoproterenol, burst pacing induced VT in 10 of 23 control mice but in only 1 of 14 transgenic mice ( P <0.05). In isolated transgenic myocytes, Ca 2+ spark frequency was reduced by 50% ( P <0.01), a reduction that persisted under isoproterenol stimulation, whereas the sarcoplasmic reticulum Ca 2+ load remained unchanged. In parallel, peak I Ca,L density decreased by 15% ( P <0.01), and the Ca 2+ transient peak amplitude decreased by 30% ( P <0.001). A 33.5% prolongation of the caffeine-evoked Ca 2+ transient decay was associated with an 18% reduction in the Na + -Ca 2+ exchanger protein level ( P <0.05). Conclusions— Increased FKBP12.6 binding to RyR2 prevents triggered VT in normal hearts in stress conditions, probably by reducing diastolic sarcoplasmic reticulum Ca 2+ leak. This indicates that the FKBP12.6-RyR2 complex is an important candidate target for pharmacological prevention of VT.

7 January 2021 in Cells
Verified
Journal Article
Open access
PDF file
Arindam DeyArindam Dey
Arindam Dey
AGAlexis Gonon
Alexis Gonon
EPEve-Isabelle Pecheur
Eve-Isabelle Pecheur
MPMylène Pezet
Mylène Pezet
CVChristian Villiers
Christian Villiers
Patrice N MARCHEPatrice N MARCHE
Patrice N MARCHE
Gold nanoparticles (AuNPs) have demonstrated outstanding performance in many biomedical applications. Their safety is recognised; however, their effects on the immune system remain ill defined. Antigen-presenting cells (APCs) are immune cells specialised in sensing external stimulus and in capturing exogenous materials then delivering signals for the immune responses. We used primary macrophages (Ms) and dendritic cells (DCs) of mice as an APC model. Whereas AuNPs did not alter significantly Ms and DCs functions, the exposure to AuNPs affected differently Ms and DCs in their responses to subsequent stimulations. The secretion of inflammatory molecules like cytokines (IL-6, TNF-α), chemokine (MCP-1), and reactive oxygen species (ROS) were altered differently in Ms and DCs. Furthermore, the metabolic activity of Ms was affected with the increase of mitochondrial respiration and glycolysis, while only a minor effect was seen on DCs. Antigen presentation to T cells increased when DCs were exposed to AuNPs leading to stronger Th1, Th2, and Th17 responses. In conclusion, our data provide new insights into the complexity of the effects of AuNPs on the immune system. Although AuNPs may be considered as devoid of significant effect, they may induce discrete modifications on some functions that can differ among the immune cells.

1 October 2013 in Hypertension
Verified
Journal Article
Closed access
PDF file
SSSéverin Slove
Séverin Slove
MLMorgane Lannoy
Morgane Lannoy
JBJacques Behmoaras
Jacques Behmoaras
MPMylène Pezet
Mylène Pezet
NSNatacha Sloboda
Natacha Sloboda
MJMarie-Paule Jacob
Marie-Paule Jacob
Hypertension is a cardiovascular disorder that appears in more than half of the patients with Williams–Beuren syndrome, hemizygous for the elastin gene among 26 to 28 other genes. It was shown that the antihypertensive drug minoxidil, an ATP-dependent potassium channel opener, enhances elastic fiber formation; however, no wide clinical application was developed because of its adverse side effects. The Brown Norway rat was used here as an arterial elastin–deficient model. We tested 3 different potassium channel openers, minoxidil, diazoxide, and pinacidil, and 1 potassium channel blocker, glibenclamide, on cultured smooth muscle cells from Brown Norway rat aorta. All tested potassium channel openers increased mRNAs encoding proteins and enzymes involved in elastic fiber formation, whereas glibenclamide had the opposite effect. The higher steady-state level of tropoelastin mRNA in minoxidil-treated cells was attributable to an increase in both transcription and mRNA stability. Treatment of Brown Norway rats for 10 weeks with minoxidil or diazoxide increased elastic fiber content and decreased cell number in the aortic media, without changing collagen content. The minoxidil-induced cardiac hypertrophy was reduced when animals simultaneously received irbesartan, an angiotensin II–receptor antagonist. This side effect of minoxidil was not observed in diazoxide-treated animals. In conclusion, diazoxide, causing less undesirable side effects than minoxidil, or coadministration of minoxidil and irbesartan, increases elastic fiber content, decreases cell number in the aorta and, thus, could be suitable for treating vascular pathologies characterized by diminished arterial elastin content and simultaneous hypertension.